Amgen Inc. has partnered with four government agencies and universities to launch a program aimed at helping cancer patients better manage their symptoms.
About 100 employees of Providence Tarzana Medical Center turned out for a picket yesterday to protest what they described as unfair labor practices.
Five people were arrested and charged on Tuesday with conducting a health insurance fraud scheme that involved patients at a pair of medical spas in the San Fernando Valley.
A nearly half-century old cancer registry managed by USC has received nearly $44 million to track the disease in Los Angeles County for the next 10 years, the university announced Monday.
Amgen Inc.’s drug Aimovig has received Food and Drug Administration approval for the prevention of migraines in adults, the first drug of its kind to do so.
The Food and Drug Administration has approved Pfizer’s application for Retacrit, a biosimilar of Amgen Inc. and Johnson & Johnson’s anemia drug Epogen.
Adventist Health has appointed Alice Issai as president of Adventist Health Glendale, the hospital system announced Monday.
Cost factors drive collaboration with clinics and doctor groups.
mPulse Mobile has closed an $11 million Series B funding round, bringing its total amount of raised capital to more than $25 million.
Second Sight Medical Products Inc. in Sylmar announced Monday that it had entered into a $10 million stock purchase agreement with entities owned by the company’s Chairman Gregg Williams
Henry Mayo Newhall Hospital in Valencia has launched its own clinically integrated network, or CIN, a collection of physicians and clinics that coordinate patient care with the objective of improving customer satisfaction and lowering costs.
The stock of MannKind Corp. jumped on Wednesday following news that the Food and Drug Administration would no longer require the company to adhere to a special plan to communicate the risks and benefits of its inhalable insulin Afrezza.
Amgen Inc. beat Wall Street expectations for earnings and revenue in its first fiscal quarter.
Amgen Inc. said a new study showed its drug Aimovig is an effective preventive treatment migraine patients who have tried other treatments that either didn’t work or had intolerable side effects, the company announced Tuesday.
Skin treatments provide youthful edge for older job-seekers and executives.